Assessment of the immunogenicity and safety of the Northern Hemisphere 2009/2010-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations.
Phase of Trial: Phase IV
Latest Information Update: 30 Jan 2012
At a glance
- Drugs Influenza virus vaccine liposomal (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Crucell
- 28 Feb 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01306253).
- 31 Aug 2009 Last checked against ISRCTN: Current Controlled Trials.
- 31 Aug 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials.